Products for Research Use Only

GZNL-P36

CAT: 0013-GTR19262320-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19262320-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
GZNL-P36 is an orally active inhibitor of SARS-CoV-2 papain-like protease (PLpro), with an IC50 of 6.45 nM. It effectively inhibits SARS-CoV and its variants, showing an EC50 ranging from 58.2 nM to 2.66 μM. In CD-1 mouse models, GZNL-P36 reaches a maximum plasma concentration (Cmax) of 549 ng/mL, with a half-life (T1/2) of 1.45 hours and a bioavailability of 74.7%. Additionally, GZNL-P36 exhibits antiviral activity in mice infected with SARS-CoV-2 XXB.1.
Field of Research
Infectious Disease & Virology
Molecular Formula
C29H30N4O2
Storage Conditions
-20°C
Notes
For research use only.

Popular Products